Site Editor

Sandy Srinivas, MD


Alicia K. Morgans, MD, MPH, on Metastatic and Nonmetastatic Prostate Cancer: New Findings on Androgen-Deprivation Therapy

Posted: Friday, March 17, 2023

Alicia K. Morgans, MD, MPH, of Dana-Farber Cancer Institute, discusses intermittent vs continuous androgen-deprivation therapy in patients with metastatic as well as nonmetastatic prostate cancer, as well as the links to cardiovascular disease and endocrine or metabolic disorders in these populations.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.